Page last updated: 2024-08-25

jatrorrhizine and Breast Neoplasms

jatrorrhizine has been researched along with Breast Neoplasms in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, YS; Huang, CC; Lee, IJ; Li, LA; Lo, SN; Ueng, YF; Wang, CW; Wu, TS	1
Dian, L; Gao, X; Li, J; Liang, Z; Sun, Y; Wink, M; Wu, P	1

Other Studies

2 other study(ies) available for jatrorrhizine and Breast Neoplasms

Article	Year
Berberine Activates Aryl Hydrocarbon Receptor but Suppresses CYP1A1 Induction through miR-21-3p Stimulation in MCF-7 Breast Cancer Cells. Molecules (Basel, Switzerland), 2017, Oct-28, Volume: 22, Issue:11 Topics: Basic Helix-Loop-Helix Transcription Factors; Berberine; Berberine Alkaloids; Breast Neoplasms; Cytochrome P-450 CYP1A1; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; MicroRNAs; Molecular Structure; Receptors, Aryl Hydrocarbon	2017
Jatrorrhizine inhibits mammary carcinoma cells by targeting TNIK mediated Wnt/β-catenin signalling and epithelial-mesenchymal transition (EMT). Phytomedicine : international journal of phytotherapy and phytopharmacology, 2019, Volume: 63 Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Berberine; beta Catenin; Breast Neoplasms; Cell Line, Tumor; Epithelial-Mesenchymal Transition; Female; Gene Knockout Techniques; Humans; Mice, Inbred BALB C; Molecular Docking Simulation; Molecular Targeted Therapy; Protein Serine-Threonine Kinases; Wnt Signaling Pathway; Xenograft Model Antitumor Assays	2019

Article

Year

Berberine Activates Aryl Hydrocarbon Receptor but Suppresses CYP1A1 Induction through miR-21-3p Stimulation in MCF-7 Breast Cancer Cells.

Molecules (Basel, Switzerland), 2017, Oct-28, Volume: 22, Issue:11

Topics: Basic Helix-Loop-Helix Transcription Factors; Berberine; Berberine Alkaloids; Breast Neoplasms; Cytochrome P-450 CYP1A1; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; MicroRNAs; Molecular Structure; Receptors, Aryl Hydrocarbon

2017

Jatrorrhizine inhibits mammary carcinoma cells by targeting TNIK mediated Wnt/β-catenin signalling and epithelial-mesenchymal transition (EMT).

Phytomedicine : international journal of phytotherapy and phytopharmacology, 2019, Volume: 63

Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Berberine; beta Catenin; Breast Neoplasms; Cell Line, Tumor; Epithelial-Mesenchymal Transition; Female; Gene Knockout Techniques; Humans; Mice, Inbred BALB C; Molecular Docking Simulation; Molecular Targeted Therapy; Protein Serine-Threonine Kinases; Wnt Signaling Pathway; Xenograft Model Antitumor Assays

2019